Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Entera Bio (NASDAQ: ENTX ) and ENTX stock are seeing massive gains of as much as 40% at the time of writing. This move comes on extremely heavy volume, with more than 150 million shares h...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Entera Bio Ltd. Announces Positive Topline Phase 2 BMD Data for EB613” Entera Bio Ltd. (NASDAQ: ENTX) surged over 59% in premarket trading after the company announ...
Current & Former Biotech Penny Stocks To Watch Right Now When it comes to hot sectors to watch in the stock market this year, biotech is definitely one that comes to mind. Thanks to excitement stemming from countless penny stocks , the mix of volatility and trading action have f...
Gainers: Entera Bio (ENTX) +56%. Orphazyme (ORPH) +47%. Bellerophon Therapeutics (BLPH) +26%. HUTCHMED (HCM) +11%. Evaxion Biotech (EVAX) +8%.Losers: Gemini Therapeutics (GMTX) -32%. Second Sight Medical Products (EYES) -19%. Millendo Therapeutics (MLND) -17...
Entera Bio (ENTX) shares jump more than 40% premarket after the company posted positive top line data from its mid-stage trial of EB613 for the treatment of osteoporosis.Osteoporosis is a disease characterized by low bone mass and structural deterioration of bone tissue, ...
Subjects receiving the 2.5 mg dose of EB613 showed significant dose-related increases in BMD at the lumbar spine, total hip, and femoral neck at 6 months Subjects receiving the 2.5 mg dose of EB613 for 6 months had a significant placebo adjusted increase of 3.78% in lumbar spine...
Gainers: Geron (GERN) +48%.CAI International (CAI) +46%.Sykes Enterprises (SYKE) +30%.PDS Biotechnology (PDSB) +18%.Smith & Wesson Brands (SWBI) +17%.Biophytis (BPTS) +13%.SemiLEDs (LEDS) +10%.Clean Energy Fuels (CLNE) +10%.Luokung Technology (LKCO) +10%.Vinco Ventures (BBIG) +9%.Los...
Gainers: Geron (GERN) +22%, AnPac Bio-Medical Science (ANPC) +20%, CureVac (CVAC) +13%, Crinetics Pharmaceuticals (CRNX) +7%, Seres Therapeutics (MCRB) +7%.Losers: Orphazyme (ORPH) -41%, Athira Pharma (ATHA) -41%, Chinook Therap...
Entera Bio (ENTX) announces the European Patent Office has granted a patent titled “Methods and Compositions for Oral Administration of Proteins”.The patent addresses Entera’s oral PTH formulations currently in advanced clinical stages for osteoporosis and hypoparathyroid...
‒ Oral delivery technology has potential to transform $20 billion injectable biologics market ‒ ‒ Final BMD results from company’s Phase 2 Osteoporosis study of EB 613 expected in Q2/2021 ‒ BOSTON and JERUSALEM, June 17, 2021 (GLO...
News, Short Squeeze, Breakout and More Instantly...